References
Ritchlin CT, Colbert RA, Gladman DD. Psoriatic arthritis. N Engl J Med 2017; 376: 957–70.
Suntharalingham JP, Buonocore F, Achermann AJ, Achermann JC. DAX–1 (NR0B1) and steroidogenic factor–1 (SF–1, NR5A1) in human disease. Best Pract Res Clin Endocrinol Metab 2015; 29: 607–19.
Jensen P, Egeberg A, Thyssen JP, Gislason G, Skov L. Psoriatic arthritis, but not psoriasis, is associated with primary adrenal insufficiency. Acta Derm Venereol 2017; 97: 519–21.
Minari R, Vottero A, Tassi F, et al. A novel mutation in the NR0B1 gene in a family with monozygotic twin sisters and congenital adrenal hypoplasia affected children. Hormones (Athens) 2015; 14: 160–6.
Steer JH, Kroeger KM, Abraham LJ, Joyce DA. Glucocorticoids suppress tumor necrosis factor–alpha expression by human monocytic THP–1 cells by suppressing transactivation through adjacent NF–kappa B and c–Jun–activating transcription factor–2 binding sites in the promoter. J Biol Chem 2000; 275: 18432–40.
Ritchlin C, Haas–Smith SA, Hicks D, Cappuccio J, Osterland CK, Looney RJ. Patterns of cytokine production in psoriatic synovium. J Rheumatol 1998; 25: 1544–52.
Coates LC, Kavanaugh A, Mease PJ, et al. Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 treatment recommendations for psoriatic arthritis. Arthritis Rheumatol 2016; 68: 1060–71.
Gossec L, Smolen JS, Ramiro S, et al. European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update. Ann Rheum Dis 2016; 75: 499–510.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Kimura, K., Fujimoto, A., Deguchi, T. et al. Successful treatment of psoriatic arthritis associated with adrenal hypoplasia congenita using infliximab. Eur J Dermatol 28, 707–708 (2018). https://doi.org/10.1684/ejd.2018.3382
Published:
Issue Date:
DOI: https://doi.org/10.1684/ejd.2018.3382